Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
NCT00001728Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- Aug 1998
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alendronate in fibrous dysplasia, McCune-Albright syndrome (MAS), sponsored by National Institute of Dental and Craniofacial Research. Started Aug 1998; status: completed.
02
Drugs
alendronate
03
Conditions
fibrous dysplasiaMcCune-Albright syndrome (MAS)
Beyond the preview
Go deeper on NCT00001728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001728.